메뉴 건너뛰기




Volumn 5, Issue 3, 2004, Pages 192-196

A one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache

Author keywords

Botulinum toxin type A; Chronic tension type headache; Costs

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; BARBITURIC ACID DERIVATIVE; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; NEUROTROPIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

EID: 20444419828     PISSN: 11292369     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10194-004-0100-3     Document Type: Article
Times cited : (4)

References (20)
  • 3
    • 0041854346 scopus 로고    scopus 로고
    • Reduction in expenditure on analgesics during one year of treatment of chronic tension headache with BoNT-A
    • Coloprisco G, De Filippis S, Santi PG, Fiore G, Rodio A, Martelletti P (2003) Reduction in expenditure on analgesics during one year of treatment of chronic tension headache with BoNT-A. J Headache Pain 4:88-91
    • (2003) J. Headache Pain , vol.4 , pp. 88-91
    • Coloprisco, G.1    De Filippis, S.2    Santi, P.G.3    Fiore, G.4    Rodio, A.5    Martelletti, P.6
  • 4
    • 1442265540 scopus 로고    scopus 로고
    • The international classification of headache disorders
    • 2nd edn. Headache Classification Subcommittee of the International Headache Society
    • Coloprisco G, De Filippis S, Santi PG, Fiore G, Rodio A, Martelletti P (2004) The international classification of headache disorders, 2nd edn. Headache Classification Subcommittee of the International Headache Society. Cephalalgia 24:S1-S150
    • (2004) Cephalalgia , vol.24
    • Coloprisco, G.1    De Filippis, S.2    Santi, P.G.3    Fiore, G.4    Rodio, A.5    Martelletti, P.6
  • 5
    • 0037227922 scopus 로고    scopus 로고
    • Analgesic therapy for headache: Consumption, appropriateness and costs
    • Iannazzo S, Cattaruzza MS, De Filippis S et al (2003) Analgesic therapy for headache: Consumption, appropriateness and costs. J Headache Pain 4:S84-S87
    • (2003) J. Headache Pain , vol.4
    • Iannazzo, S.1    Cattaruzza, M.S.2    De Filippis, S.3
  • 6
    • 0043234545 scopus 로고    scopus 로고
    • Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: From bench to bedside
    • Dodick DW (2003) Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: From bench to bedside. Headache 43[Suppl 1]:25-33
    • (2003) Headache , vol.43 , Issue.SUPPL. 1 , pp. 25-33
    • Dodick, D.W.1
  • 7
    • 0043239363 scopus 로고    scopus 로고
    • Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders
    • Blumenfeld A (2003) Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders. Headache 43:853-860
    • (2003) Headache , vol.43 , pp. 853-860
    • Blumenfeld, A.1
  • 8
    • 0033917504 scopus 로고    scopus 로고
    • Botulinum toxin type A as a migraine preventive treatment
    • for the BOTOX® Migraine Clinical Research Group
    • Silberstein S, Mathew N, Saper J, Jenkins S, for the BOTOX® Migraine Clinical Research Group (2000) Botulinum toxin type A as a migraine preventive treatment. Headache 40:445-450
    • (2000) Headache , vol.40 , pp. 445-450
    • Silberstein, S.1    Mathew, N.2    Saper, J.3    Jenkins, S.4
  • 9
    • 0347123546 scopus 로고    scopus 로고
    • Botulinum toxin type A (BOTOX®) in the treatment of migraine and other headaches
    • Troost BT (2004) Botulinum toxin type A (BOTOX®) in the treatment of migraine and other headaches. Expert Rev Neurother 4:27-31
    • (2004) Expert. Rev. Neurother. , vol.4 , pp. 27-31
    • Troost, B.T.1
  • 10
    • 0033392026 scopus 로고    scopus 로고
    • Prophylactic treatment of chronic tension-type headache using botulinum toxin type A
    • Smuts J, Baker M, Smuts H (1999) Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 6[Suppl 4]:S99-S102
    • (1999) Eur. J. Neurol. , vol.6 , Issue.SUPPL. 4
    • Smuts, J.1    Baker, M.2    Smuts, H.3
  • 11
    • 0345802553 scopus 로고    scopus 로고
    • Botulinum toxin type A in prophylactic treatment of migraine headaches: A preliminary study
    • Barrientos N, Chana P (2003) Botulinum toxin type A in prophylactic treatment of migraine headaches: A preliminary study. J Headache Pain 4:146-151
    • (2003) J. Headache Pain , vol.4 , pp. 146-151
    • Barrientos, N.1    Chana, P.2
  • 12
    • 0346094042 scopus 로고    scopus 로고
    • Effect of preventive treatment with botulinum toxin type A on acute headache medication usage in migraine patients
    • Schim J (2004) Effect of preventive treatment with botulinum toxin type A on acute headache medication usage in migraine patients. Curr Med Res Opin 20:49-53
    • (2004) Curr. Med. Res. Opin. , vol.20 , pp. 49-53
    • Schim, J.1
  • 13
    • 0142119376 scopus 로고    scopus 로고
    • The burden of brain diseases in Europe
    • Olesen J, Leonardi M (2003) The burden of brain diseases in Europe. Eur J Neurol 10:471-477
    • (2003) Eur. J. Neurol. , vol.10 , pp. 471-477
    • Olesen, J.1    Leonardi, M.2
  • 14
    • 20444362974 scopus 로고    scopus 로고
    • Social cost of diseases: Methods and impact in health system
    • Marini A, Colombo GL, Pana A et al (2002) Social cost of diseases: methods and impact in health system. Ig Sanita Pubbl 8:315-316
    • (2002) Ig. Sanita Pubbl. , vol.8 , pp. 315-316
    • Marini, A.1    Colombo, G.L.2    Pana, A.3
  • 15
    • 1442276262 scopus 로고    scopus 로고
    • Measuring disability and quality of life in migraine
    • Dahlof CG (2003) Measuring disability and quality of life in migraine. Drugs Today 39[Suppl D]:17-23
    • (2003) Drugs Today , vol.39 , Issue.SUPPL. D , pp. 17-23
    • Dahlof, C.G.1
  • 16
    • 1542319122 scopus 로고    scopus 로고
    • Planning analyses of quality-of-life studies: A case example with migraine prophylaxis
    • Fairclough DL, Gagnon D, Papadopoulos G (2004) Planning analyses of quality-of-life studies: A case example with migraine prophylaxis. J Biopharm Stat 14:31-51
    • (2004) J. Biopharm. Stat. , vol.14 , pp. 31-51
    • Fairclough, D.L.1    Gagnon, D.2    Papadopoulos, G.3
  • 18
    • 1642366114 scopus 로고    scopus 로고
    • A review of self-report instruments measuring health-related work-productivity: A patient-reported outcome perspective
    • Prasad M, Wahlquist P, Shikiar R, Shih YC (2004) A review of self-report instruments measuring health-related work-productivity: A patient-reported outcome perspective. Pharmacoeconomics 22:225-244
    • (2004) Pharmacoeconomics , vol.22 , pp. 225-244
    • Prasad, M.1    Wahlquist, P.2    Shikiar, R.3    Shih, Y.C.4
  • 19
    • 0242410368 scopus 로고    scopus 로고
    • Lost productive time and cost due to common pain condition in the US workforce
    • Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R (2004) Lost productive time and cost due to common pain condition in the US workforce. JAMA 290:2443-2454
    • (2004) JAMA , vol.290 , pp. 2443-2454
    • Stewart, W.F.1    Ricci, J.A.2    Chee, E.3    Morganstein, D.4    Lipton, R.5
  • 20
    • 0037387344 scopus 로고    scopus 로고
    • Health-related workplace productivity measurement: General and migraine specific recommendations from the ACOEM Expert Panel
    • Loeppke R, Hymel PA, Lofland JH et al (2003) Health-related workplace productivity measurement: General and migraine specific recommendations from the ACOEM Expert Panel. J Occup Environ Med 45:349-359
    • (2003) J. Occup. Environ. Med. , vol.45 , pp. 349-359
    • Loeppke, R.1    Hymel, P.A.2    Lofland, J.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.